Bacterial Infections  >>  Cayston (aztreonam lysine)  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Cayston (aztreonam lysine) / Gilead
NCT00499720 / 2015-000396-26: Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis and Pseudomonas Aeruginosa Airway Infection

Approved for marketing
N/A
US
Aztreonam Lysine for Inhalation
Gilead Sciences
Cystic Fibrosis, Pseudomonas Aeruginosa Airway Infection
 
 
NCT00989807 / 2015-000397-36: Expanded Access Program for Aztreonam Lysine for Inhalation in Canadian Patients With Cystic Fibrosis

Approved for marketing
N/A
Canada
Aztreonam lysine
Gilead Sciences
Cystic Fibrosis, Pseudomonas Aeruginosa
 
 

Download Options